Chronic Myeloproliferative Disorders

Showing NaN - NaN of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Volunteers of Fanconi Anemia, Myeloproliferative

Completed
  • Chronic Myeloproliferative Disorders
  • +3 more
  • microarray analysis
  • +8 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Jun 30, 2022

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)

Terminated
  • Chronic Myeloproliferative Disorders
  • +6 more
  • anti-thymocyte globulin
  • +16 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 25, 2017

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Portland (biological, drug, procedure, radiation)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • therapeutic allogeneic lymphocytes
  • +9 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Sep 25, 2017

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (baclofen/amitriptyline/ketamine gel, )

Completed
  • Chronic Myeloproliferative Disorders
  • +9 more
  • baclofen/amitriptyline/ketamine gel
  • placebo
  • Scottsdale, Arizona
  • +164 more
Jul 25, 2017

Blood Samples From Patients onClinical Trial to CINV During HSCT

Terminated
  • Breast Cancer
  • +11 more
  • immunoenzyme technique
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 7, 2017

Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial in Portland (moxifloxacin HCl, Placebo)

Terminated
  • Breast Cancer
  • +11 more
  • moxifloxacin hydrochloride
  • Placebo
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
May 7, 2017

Chronic Myeloproliferative Disorders, Fatigue, Leukemia Trial in United States (American ginseng, )

Completed
  • Chronic Myeloproliferative Disorders
  • +9 more
  • American ginseng
  • placebo
  • Scottsdale, Arizona
  • +325 more
Dec 19, 2016

Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker

Completed
  • Chronic Myeloproliferative Disorders
  • +4 more
  • ruxolitinib phosphate
  • +2 more
  • Birmingham, Alabama
  • +23 more
Oct 22, 2014

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Portland (biological, drug, procedure, radiation)

Terminated
  • Chronic Myeloproliferative Disorders
  • +7 more
  • filgrastim
  • +7 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 24, 2012

Chronic Myeloproliferative Disorders Trial in Portland (imatinib mesylate)

Terminated
  • Chronic Myeloproliferative Disorders
  • imatinib mesylate
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 1, 2011